06-Feb-2020 | Facts and Factors
Facts and Factors has authored “Nerve Gas Auto-Injector Market By Type (Devices, Formulation) and By Application (Atropine, Pralidoximechloride, Diazepam, Morphine): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026”. Based on our analysis, the global Nerve Gas Auto-Injector market in 2019 is approximately USD 14 Billion and is anticipated to reach around USD 16 Billion by 2026. The anticipated CAGR for the Nerve Gas Auto-Injector market is around 1.5% from 2020 to 2026.
Nerve gas auto-injectors are used for the cure of poisoning by organophosphorus nerve agents and due to organophosphorus insecticides. The market is divided into devices and formulations segments. The injectable drug delivery technology used in these auto-injectors is based on these two segments. Atropine, diazepam, morphine, and pralidoximechloride are the antidotes that can treat people exposed to nerve agents. These antidotes are packed in devices to administer antidote by injecting into humans through auto-injectors. Nerve gases can be colorless or yellow-brown liquids under standard conditions Nerve gas auto-injectors act as self-help equipment that helps army personnel to help themselves from poisoning by different chemicals.
Browse the full “Nerve Gas Auto-Injector Market By Type (Devices, Formulation) and By Application (Atropine, Pralidoximechloride, Diazepam, Morphine): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026” report at https://www.fnfresearch.com/nerve-gas-auto-injector-market
Increase in the need of the nerve gas auto-injector in the defense sector is one of the driving factors for the nerve gas auto-injector market. Rising demand for Atropine auto-injectors is anticipated and is one of the driving factors for the nerve gas auto-injector market. Though there is a shortage of auto-injectors globally due to manufacturing problems of auto-injectors and has created a set back for the development of the nerve gas auto-injector market. But new products are continuously launched and there is a growing innovation in nerve gas auto-injectors opening new future opportunities for the market growth.
The nerve gas auto-injector market is divided into segments based on its type and applications. The type segment is divided into devices and formulation segment. The application segment is divided into Atropine, Diazepam, Pralidoximechloride, Morphine segments. Atropine, Diazepam, Morphine, Pralidoximechloride are different types of antidotes that are packed in auto-injectors to inject into humans. In the type segment, it is anticipated that formulation sub-segment is to grow rapidly over the forecast period. In the application segment, Atropine sub-segment is anticipated to grow with more pace over the forecast years as there is a rising demand for Atropine auto-injectors in defense and military sectors. Followed by Atropine, Pralidoximechloride is anticipated to have the second-largest market share in the application segment.
North America is anticipated to have the largest market share of the nerve gas auto-injector market followed bu Europe. In North America, the U.S. is estimated to have the largest market share. In Europe, France is anticipated to have the largest market share. North America has almost 21.5 Million military personnel and hence a large demand from the region is seen for the nerve gas auto-injectors. Growing demand for nerve gas auto-injectors is anticipated globally due to the new development of products and innovation of the product. Asia-Pacific region is anticipated to grow at the highest CAGR associated with the highest value share in the upcoming years.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 14 Billion |
Projected Market Size in 2026 |
USD 16 Billion |
CAGR Growth Rate |
1.5% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
Owen Mumford, Sopharma, Hospira, Meridian Medical Technologies, Hikma Pharmaceuticals Plc, Ypsomed Holding AG, Sanofi S.A., and others. |
Key Segment |
By Type , Application, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
The major market players of the nerve gas auto-injector market are, Owen Mumford, Sopharma, Hospira, Meridian Medical Technologies, Hikma Pharmaceuticals Plc, Ypsomed Holding AG, Sanofi S.A., and others.
This report segments the Nerve Gas Auto-Injector market as follows:
Global Nerve Gas Auto-Injector Market: By Type Segment Analysis
Global Nerve Gas Auto-Injector Market: By Application Segment Analysis
- Atropine
- Pralidoximechloride
- Diazepam
- Morphine
Global Nerve Gas Auto-Injector Market: Regional Segment Analysis
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- South-East Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- The Middle-East and Africa
- GCC Countries
- South Africa
- Rest of Middle-East Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
